Cargando…

Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity

A malignant solitary fibrous tumor arising from the omentum is extremely rare. To our knowledge, this is the first case of a malignant solitary fibrous omentum tumor coexisting with uterine corpus cancer. A 62-year-old woman presented to our hospital with vaginal discharge. Endometrioid adenocarcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Naoya, Nobuhara, Ichiro, Haruta, Noriko, Higashiura, Yumi, Watanabe, Hideki, Ohno, Sumire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120779/
https://www.ncbi.nlm.nih.gov/pubmed/25114818
http://dx.doi.org/10.1155/2014/216340
_version_ 1782329142282289152
author Harada, Naoya
Nobuhara, Ichiro
Haruta, Noriko
Higashiura, Yumi
Watanabe, Hideki
Ohno, Sumire
author_facet Harada, Naoya
Nobuhara, Ichiro
Haruta, Noriko
Higashiura, Yumi
Watanabe, Hideki
Ohno, Sumire
author_sort Harada, Naoya
collection PubMed
description A malignant solitary fibrous tumor arising from the omentum is extremely rare. To our knowledge, this is the first case of a malignant solitary fibrous omentum tumor coexisting with uterine corpus cancer. A 62-year-old woman presented to our hospital with vaginal discharge. Endometrioid adenocarcinoma was diagnosed by endometrial curettage. In addition, a solid tumor in front of the uterus was detected following computed tomography and/or magnetic resonance imaging, which was suspected to be a primary (or secondary) malignant tumor arising from the omentum. Hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and lymphadenectomy were performed. A malignant solitary fibrous tumor of the omentum and grade 3 endometrioid adenocarcinoma of the uterus were diagnosed by pathohistological analysis. Interestingly, the tumor cells were immunoreactive for p53. Adjuvant chemotherapy was administered for the uterine corpus cancer and the patient remains healthy 48 months after the surgery. These tumors may have become malignant due to the presence of p53 mutations.
format Online
Article
Text
id pubmed-4120779
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-41207792014-08-11 Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity Harada, Naoya Nobuhara, Ichiro Haruta, Noriko Higashiura, Yumi Watanabe, Hideki Ohno, Sumire Case Rep Obstet Gynecol Case Report A malignant solitary fibrous tumor arising from the omentum is extremely rare. To our knowledge, this is the first case of a malignant solitary fibrous omentum tumor coexisting with uterine corpus cancer. A 62-year-old woman presented to our hospital with vaginal discharge. Endometrioid adenocarcinoma was diagnosed by endometrial curettage. In addition, a solid tumor in front of the uterus was detected following computed tomography and/or magnetic resonance imaging, which was suspected to be a primary (or secondary) malignant tumor arising from the omentum. Hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and lymphadenectomy were performed. A malignant solitary fibrous tumor of the omentum and grade 3 endometrioid adenocarcinoma of the uterus were diagnosed by pathohistological analysis. Interestingly, the tumor cells were immunoreactive for p53. Adjuvant chemotherapy was administered for the uterine corpus cancer and the patient remains healthy 48 months after the surgery. These tumors may have become malignant due to the presence of p53 mutations. Hindawi Publishing Corporation 2014 2014-07-10 /pmc/articles/PMC4120779/ /pubmed/25114818 http://dx.doi.org/10.1155/2014/216340 Text en Copyright © 2014 Naoya Harada et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Harada, Naoya
Nobuhara, Ichiro
Haruta, Noriko
Higashiura, Yumi
Watanabe, Hideki
Ohno, Sumire
Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity
title Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity
title_full Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity
title_fullStr Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity
title_full_unstemmed Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity
title_short Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity
title_sort concurrent malignant solitary fibrous tumor arising from the omentum and grade 3 endometrial endometrioid adenocarcinoma of the uterus with p53 immunoreactivity
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120779/
https://www.ncbi.nlm.nih.gov/pubmed/25114818
http://dx.doi.org/10.1155/2014/216340
work_keys_str_mv AT haradanaoya concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity
AT nobuharaichiro concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity
AT harutanoriko concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity
AT higashiurayumi concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity
AT watanabehideki concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity
AT ohnosumire concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity